These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29462644)

  • 1. Hepatic and cardiac hemodynamics and systemic inflammation in cirrhosis: It takes three to tango.
    Coenraad MJ; Porcher R; Bendtsen F
    J Hepatol; 2018 May; 68(5):887-889. PubMed ID: 29462644
    [No Abstract]   [Full Text] [Related]  

  • 2. Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.
    Tripathi DM; Vilaseca M; Lafoz E; Garcia-Calderó H; Viegas Haute G; Fernández-Iglesias A; Rodrigues de Oliveira J; García-Pagán JC; Bosch J; Gracia-Sancho J
    Gastroenterology; 2018 Nov; 155(5):1564-1577. PubMed ID: 30055171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil gelatinase-associated lipocalin and cystatin C in cirrhosis and portal hypertension: Relations to organ extraction and dysfunction.
    Hurry PK; Poulsen JH; Bendtsen F; Møller S
    J Gastroenterol Hepatol; 2017 Feb; 32(2):473-481. PubMed ID: 27435243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality.
    Lehmann JM; Claus K; Jansen C; Pohlmann A; Schierwagen R; Meyer C; Thomas D; Manekeller S; Claria J; Strassburg CP; Trautwein C; Wasmuth HE; Berres ML; Trebicka J
    Liver Int; 2018 May; 38(5):875-884. PubMed ID: 29105936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac and proinflammatory markers predict prognosis in cirrhosis.
    Wiese S; Mortensen C; Gøtze JP; Christensen E; Andersen O; Bendtsen F; Møller S
    Liver Int; 2014 Jul; 34(6):e19-30. PubMed ID: 24313898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of central and porto-hepatic hemodynamics before the surgical treatment of patients with liver cirrhosis and portal hypertension].
    Eramishantsev AK; Gogichaĭshvili SSh; Lebezev VM; Kitsenko EA; Dolidze MA
    Klin Med (Mosk); 1991 Feb; 69(2):81-3. PubMed ID: 1875671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemodynamic and functional aspects of portal hypertension decompensation in liver cirrhosis].
    Kalita NIa; Kotenko OG; Bulanov KI; Furmanenko ED; Egorova OE
    Klin Khir (1962); 1994; (11):37-41. PubMed ID: 7658658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Sapropterin on Portal and Systemic Hemodynamics in Patients With Cirrhosis and Portal Hypertension: A Bicentric Double-Blind Placebo-Controlled Study.
    Reverter E; Mesonero F; Seijo S; Martínez J; Abraldes JG; Peñas B; Berzigotti A; Deulofeu R; Bosch J; Albillos A; García-Pagán JC
    Am J Gastroenterol; 2015 Jul; 110(7):985-92. PubMed ID: 26077176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute-on-chronic liver failure: the liver and portal haemodynamics.
    Mookerjee RP
    Curr Opin Crit Care; 2011 Apr; 17(2):170-6. PubMed ID: 21346568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of molsidomine on portal and cardiac hemodynamics in liver cirrhosis].
    Hüppe D; Jäger D; Tromm A; Tunn S; Barmeyer J; May B
    Dtsch Med Wochenschr; 1991 May; 116(22):841-5. PubMed ID: 2036943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma ADAMTS-13 protein is not associated with portal hypertension or hemodynamic changes in patients with cirrhosis.
    Wiese S; Timm A; Nielsen LB; Goetze JP; Bendtsen F; Møller S
    Dig Liver Dis; 2016 Apr; 48(4):404-8. PubMed ID: 26775093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.
    Lens S; Alvarado-Tapias E; Mariño Z; Londoño MC; LLop E; Martinez J; Fortea JI; Ibañez L; Ariza X; Baiges A; Gallego A; Bañares R; Puente A; Albillos A; Calleja JL; Torras X; Hernández-Gea V; Bosch J; Villanueva C; Forns X; García-Pagán JC
    Gastroenterology; 2017 Nov; 153(5):1273-1283.e1. PubMed ID: 28734831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, laboratory, and hemodynamic parameters in portal hypertensive gastropathy: a study of 254 cirrhotics.
    Kumar A; Mishra SR; Sharma P; Sharma BC; Sarin SK
    J Clin Gastroenterol; 2010 Apr; 44(4):294-300. PubMed ID: 19730114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension.
    Merkel C; Gatta A; Zuin R; Finucci GF; Nosadini R; Ruol A
    Digestion; 1985; 32(2):92-8. PubMed ID: 2864299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
    Bosch J; Kravetz D; Rodes J
    Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.
    La Mura V; Reverter JC; Flores-Arroyo A; Raffa S; Reverter E; Seijo S; Abraldes JG; Bosch J; García-Pagán JC
    Gut; 2011 Aug; 60(8):1133-8. PubMed ID: 21427197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
    Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systemic circulatory hyperkinetic syndrome in patients with cirrhosis. Relation with hepatocellular failure and portal hypertension].
    Valla D; Poynard T; Bercoff E; Bataille C; Goldfarb G; Lebrec D
    Gastroenterol Clin Biol; 1984 Apr; 8(4):321-4. PubMed ID: 6735039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of portal hemodynamics on Doppler ultrasonography for predicting decompensation and long-term outcomes in patients with cirrhosis.
    Kondo T; Maruyama H; Sekimoto T; Shimada T; Takahashi M; Okugawa H; Yokosuka O
    Scand J Gastroenterol; 2016; 51(2):236-44. PubMed ID: 26357874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of Radix angelicae sinensis on systemic and portal hemodynamics in cirrhotics with portal hypertension].
    Huang Z; Guo B; Liang K
    Zhonghua Nei Ke Za Zhi; 1996 Jan; 35(1):15-8. PubMed ID: 9275639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.